BACKGROUND: Hypoalbuminemia is a well-recognized finding associated with cancer, but its prevalence and prognostic significance have not been well studied in children with cancer. OBJECTIVE: To determine the prevalence of hypoalbuminemia prior to starting chemotherapy in children with cancer and its association with relapse-free survival (RFS) and overall survival (OS). DESIGN/ METHOD: We performed a single institution, IRB-approved, retrospective review of pediatric oncology patients diagnosed between 1998 and 2012. Five-year survival was estimated using the Kaplan-Meier method; groups were compared using Cox regression. RESULTS: We identified 659 pediatric patients with a first diagnosis of cancer and a serum albumin level prior to starting chemotherapy. Mean age was 8.6 years (SD = 5.8); 62% were male and 92% were non-Hispanic. Hypoalbuminemia prior to starting chemotherapy was present at least once in 302 (45.8%). The five-year RFS and OS of those with hypoalbuminemia and without hypoalbuminemia were not significantly different. However, patients with severe hypoalbuminemia (defined as a value 10% or more below the lower limit of normal) had inferior RFS and OS for patients with hematologic/lymphatic malignancies, and inferior RFS for patients with metstatic Ewing sarcoma. CONCLUSION: Hypoalbuminemia prior to starting chemotherapy in pediatric oncology patients is common (nearly half in this cohort). Severe hypoalbuminemia was associated with inferior 5-year RFS in some subgroups.
BACKGROUND:Hypoalbuminemia is a well-recognized finding associated with cancer, but its prevalence and prognostic significance have not been well studied in children with cancer. OBJECTIVE: To determine the prevalence of hypoalbuminemia prior to starting chemotherapy in children with cancer and its association with relapse-free survival (RFS) and overall survival (OS). DESIGN/ METHOD: We performed a single institution, IRB-approved, retrospective review of pediatric oncology patients diagnosed between 1998 and 2012. Five-year survival was estimated using the Kaplan-Meier method; groups were compared using Cox regression. RESULTS: We identified 659 pediatric patients with a first diagnosis of cancer and a serum albumin level prior to starting chemotherapy. Mean age was 8.6 years (SD = 5.8); 62% were male and 92% were non-Hispanic. Hypoalbuminemia prior to starting chemotherapy was present at least once in 302 (45.8%). The five-year RFS and OS of those with hypoalbuminemia and without hypoalbuminemia were not significantly different. However, patients with severe hypoalbuminemia (defined as a value 10% or more below the lower limit of normal) had inferior RFS and OS for patients with hematologic/lymphatic malignancies, and inferior RFS for patients with metstatic Ewing sarcoma. CONCLUSION:Hypoalbuminemia prior to starting chemotherapy in pediatric oncology patients is common (nearly half in this cohort). Severe hypoalbuminemia was associated with inferior 5-year RFS in some subgroups.
Authors: Andrew R Rezvani; Barry E Storer; Rainer F Storb; Marco Mielcarek; David G Maloney; Brenda M Sandmaier; Paul J Martin; George B McDonald Journal: Biol Blood Marrow Transplant Date: 2011-07-30 Impact factor: 5.742
Authors: Cindy L Schwartz; Lu Chen; Kathleen McCarten; Suzanne Wolden; Louis S Constine; Robert E Hutchison; Pedro A de Alarcon; Frank G Keller; Kara M Kelly; Tanya A Trippet; Stephan D Voss; Debra L Friedman Journal: Pediatr Blood Cancer Date: 2016-10-27 Impact factor: 3.167
Authors: Rami S Komrokji; Maria Corrales-Yepez; Mohamed A Kharfan-Dabaja; Najla H Al Ali; Eric Padron; Dana E Rollison; Javier Pinilla-Ibarz; Ling Zhang; Pearlie K Epling-Burnette; Jeffrey E Lancet; Alan F List Journal: Am J Hematol Date: 2012-08-01 Impact factor: 10.047
Authors: Samantha N Reiss; Larry W Buie; Nelly Adel; Debra A Goldman; Sean M Devlin; Dan Douer Journal: Ann Hematol Date: 2016-08-20 Impact factor: 3.673